SCHEMBL3089617

SCHEMBL3089617

O=C(c1cnc(-c2ccc(F)c(F)c2)s1)C(F)(F)F

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 5/20 0.65
HDAC1 Q13547 3/20 0.65
HDAC4 P56524 1/20 0.44
SMN1; SMN2 Q16637 6/20 0.44
NPC1 O15118 6/20 0.44
RAB9A P51151 6/20 0.44
POLB P06746 2/20 0.44
MAPT P10636 4/20 0.43
PPARG P37231 2/20 0.42
NCOA2 Q15596 2/20 0.42
NCOA1 Q15788 2/20 0.42
NCOA3 Q9Y6Q9 2/20 0.42
HPGD P15428 1/20 0.42
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
PTPN11 Q06124 1/20 0.40
STK17B O94768 1/20 0.39
ALDH1A1 P00352 4/20 0.39
ULK1 O75385 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16702935 0.84 SMN1; SMN2 (0.47) HDAC6HDAC1SMN1; SMN2NPC1RAB9A
SCHEMBL3097654 0.82 HDAC6 (0.73) HDAC6HDAC1HDAC4SMN1; SMN2NPC1
SCHEMBL3080184 0.82 HDAC6 (0.63) HDAC6HDAC1HDAC4SMN1; SMN2NPC1
SCHEMBL3094096 0.81 HDAC6 (0.70) HDAC6HDAC1HDAC4SMN1; SMN2NPC1
SCHEMBL3095160 0.79 HDAC6 (0.73) HDAC6HDAC1HDAC4SMN1; SMN2NPC1
SCHEMBL3100772 0.79 HDAC6 (0.94) HDAC6HDAC1HDAC4SMN1; SMN2NPC1
SCHEMBL3087014 0.79 HDAC6 (1.00) HDAC6HDAC1HDAC4SMN1; SMN2NPC1
SCHEMBL3101373 0.77 HDAC6 (0.69) HDAC6HDAC1HDAC4SMN1; SMN2NPC1
SCHEMBL2225279 0.77 HDAC6 (0.72) HDAC6HDAC1HDAC4SMN1; SMN2NPC1
SCHEMBL16051896 0.77 HDAC6 (0.68) HDAC6HDAC1HDAC4SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1987024-B1 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS MSD ITALIA SRL (IT) 2016-10-19 EP disclosed
US-7799825-B2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2010-09-21 US disclosed
US-20090076101-A1 Thiophene and Thiazole Substituted Trifluoroethanone Derivatives as Histone Deacetylase (HDAC) Inhibitors MSD ITALIA S.R.L. (IT) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076101-A1 Thiophene and Thiazole Substituted Trifluoroethanone Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC1, HDAC4, HDAC7 HDAC6 10/4885HDAC1 1/4885HDAC4 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.